Lauren A. Do, Tufts Medical Center, Boston, Massachusetts.
Benjamin C. Koethe, Tufts Medical Center.
Health Aff (Millwood). 2022 Sep;41(9):1281-1290. doi: 10.1377/hlthaff.2022.00325.
Low-value care is a major source of health care inefficiency in the US. Our analysis of 2009-19 administrative claims data from OptumLabs Data Warehouse found that low-value care and associated spending remain prevalent among commercially insured and Medicare Advantage enrollees. The aggregated prevalence of twenty-three low-value services was 1,920 per 100,000 eligible enrollees, which amounted to $3.7 billion in wasteful expenditures during the study period. State-level variation in spending was greater than variation in utilization, and much of the variation in spending was driven by differences in average procedure prices. If the average price for twenty-three low-value services among the top ten states in spending were set to the national average, their spending would decrease by 19.8 percent (from $735,000 to $590,000 per 100,000 eligible enrollees). State-level actions to improve the routine measurement and reporting of low-value care could identify sources of variation and help design state-specific policies that lead to better patient-centered outcomes, enhanced equity, and more efficient spending.
低价值医疗是美国医疗效率低下的一个主要原因。我们对 OptumLabs Data Warehouse 2009-19 年管理索赔数据的分析发现,低价值医疗和相关支出在商业保险和医疗保险优势计划参保者中仍然普遍存在。23 项低价值服务的总流行率为每 10 万合格参保者中有 1920 例,在研究期间造成了 37 亿美元的浪费性支出。支出方面的州级差异大于利用率方面的差异,支出方面的大部分差异是由平均程序价格的差异驱动的。如果支出最高的十个州的 23 项低价值服务的平均价格设定为全国平均水平,其支出将减少 19.8%(每 10 万合格参保者从 73.5 万美元降至 59 万美元)。改善低价值医疗常规测量和报告的州级行动可以确定差异的来源,并帮助设计针对特定州的政策,从而实现更好的以患者为中心的结果、增强公平性和更有效的支出。